French Glendon E. III's Form 4 filing
Pulmonx Corp (LUNG) · filed Sep 18, 2024
- Accession no.
- 0001415889-24-023654
- Filed
- Sep 18, 2024
- Trade date
- Sep 12, 2024
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $161.8K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| French Glendon E. IIICIK 0001805624 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Common Stock | SSaleDisposed | −20,000 | $8.09 | −$161,800 | 1,111,974 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.